HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Babiker, A. Articles by Björkhem, I. Search for Related Content PubMed PubMed Citation Articles by Babiker, A. Articles by Björkhem, I. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 40, 1417-1425, August 1999
Copyright © 1999 by Lipid Research, Inc.

Original Article

Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin

Correspondence to: Ingemar Björkhem

Human alveolar macrophages have exceptionally high capacity to convert cholesterol into 27-hydroxycholesterol and cholestenoic acid by the sterol 27-hydroxylase mechanism. It is shown here that the human lung has a higher content of 27-hydroxycholesterol relative to cholesterol than any other organ. In order to evaluate the importance of the sterol 27-hydroxylase mechanism for cholesterol homeostasis in the lung, the production of cholestenoic acid by human lung was investigated. Removal of one lung reduced the level of cholestenoic acid in the circulation by 48 ± 4% (P < 0.005). The levels of cholestenoic acid in the pulmonary artery and in the pulmonary vein showed significant differences (P < 0.002) with higher levels in the pulmonary vein (108 ± 16 and 104 ± 16 ng/mL, respectively). This corresponds to a net flux of cholestenoic acid from the lung of about 14 mg/day, which is more than 80% of the reported removal of this oxysterol and its metabolites from the circulation by the liver per day. Bypassing the lung for 60 min led to a reduction in circulating cholestenoic acid (30%) that fits with a pulmonary origin when taking into account the half-life of cholestenoic acid. The level of circulating cholestenoic acid was found to be less in patients with different lung diseases. It is evident that most of the cholestenoic acid in the circulation is of pulmonary origin.

The present results suggest that the sterol 27-hydroxylase in the lung is responsible for at least half of the total flux of 27-oxygenated cholesterol metabolites to the liver and that this enzyme system may be of importance for cholesterol homeostasis in the lung.—Babiker, A., O. Andersson, D. Lindblom, J. van der Linden, B. Wiklund, D. Lütjohann, U. Diczfalusy, and I. Björkhem. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 1999. 40: 1417;–1425.

Supplementary key words: pulmonary cholesterol, cytochrome P-450, isotope dilution–mass spectrometry, 27-hydroxycholesterol

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Smoak, J. Madenspacher, S. Jeyaseelan, B. Williams, D. Dixon, K. R. Poch, J. A. Nick, G. S. Worthen, and M. B. Fessler Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense J. Immunol., March 1, 2008; 180(5): 3305 - 3312. [Abstract] [Full Text] [PDF]

				J. D. Davies, K. L. H. Carpenter, I. R. Challis, N. L. Figg, R. McNair, D. Proudfoot, P. L. Weissberg, and C. M. Shanahan Adipocytic Differentiation and Liver X Receptor Pathways Regulate the Accumulation of Triacylglycerols in Human Vascular Smooth Muscle Cells J. Biol. Chem., February 4, 2005; 280(5): 3911 - 3919. [Abstract] [Full Text] [PDF]

				S. Meaney, T. L. Bonfield, M. Hansson, A. Babiker, M. S. Kavuru, and M. J. Thomassen Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis J. Lipid Res., December 1, 2004; 45(12): 2354 - 2360. [Abstract] [Full Text] [PDF]

				A. Szanto, S. Benko, I. Szatmari, B. L. Balint, I. Furtos, R. Ruhl, S. Molnar, L. Csiba, R. Garuti, S. Calandra, et al. Transcriptional Regulation of Human CYP27 Integrates Retinoid, Peroxisome Proliferator-Activated Receptor, and Liver X Receptor Signaling in Macrophages Mol. Cell. Biol., September 15, 2004; 24(18): 8154 - 8166. [Abstract] [Full Text] [PDF]

				M. Heverin, N. Bogdanovic, D. Lutjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Bjorkhem Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease J. Lipid Res., January 1, 2004; 45(1): 186 - 193. [Abstract] [Full Text] [PDF]

				Y. Ota, T.-A. Eto, S.-I. Tanaka, H. Sueta, H. Shiotsuki, Y. Maeda, M. Une, and K. Chijiiwa Assay method for mitochondrial sterol 27-hydroxylase with 7{alpha}-hydroxy-4-cholesten-3-one as a substrate in the rat liver J. Lipid Res., December 1, 2003; 44(12): 2400 - 2405. [Abstract] [Full Text] [PDF]

				V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Bjorkhem Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers J. Lipid Res., April 1, 2003; 44(4): 793 - 799. [Abstract] [Full Text] [PDF]

				J. Linseisen, G. Wolfram, and A. B. Miller Plasma 7{beta}-Hydroxycholesterol as a Possible Predictor of Lung Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1630 - 1637. [Abstract] [Full Text] [PDF]

				J. Y. L. Chiang Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors Endocr. Rev., August 1, 2002; 23(4): 443 - 463. [Abstract] [Full Text] [PDF]

				X. Fu, J. G. Menke, Y. Chen, G. Zhou, K. L. MacNaul, S. D. Wright, C. P. Sparrow, and E. G. Lund 27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells J. Biol. Chem., October 12, 2001; 276(42): 38378 - 38387. [Abstract] [Full Text] [PDF]

				Z. Zhang, D. Li, D. E. Blanchard, S. R. Lear, S. K. Erickson, and T. A. Spencer Key regulatory oxysterols in liver: analysis as {{Delta}}4-3-ketone derivatives by HPLC and response to physiological perturbations J. Lipid Res., April 1, 2001; 42(4): 649 - 658. [Abstract] [Full Text]

				I. Björkhem, L. Starck, U. Andersson, D. Lütjohann, S. von Bahr, I. Pikuleva, A. Babiker, and U. Diczfalusy Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol J. Lipid Res., March 1, 2001; 42(3): 366 - 371. [Abstract] [Full Text]

				M. Norlin, A. Toll, I. Björkhem, and K. Wikvall 24-Hydroxycholesterol is a substrate for hepatic cholesterol 7{alpha}-hydroxylase (CYP7A) J. Lipid Res., October 1, 2000; 41(10): 1629 - 1639. [Abstract] [Full Text]

				L. Bretillon, D. Lütjohann, L. Ståhle, T. Widhe, L. Bindl, G. Eggertsen, U. Diczfalusy, and I. Björkhem Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J. Lipid Res., May 1, 2000; 41(5): 840 - 845. [Abstract] [Full Text]

				J. Li-Hawkins, E. G. Lund, A. D. Bronson, and D. W. Russell Expression Cloning of an Oxysterol 7alpha -Hydroxylase Selective for 24-Hydroxycholesterol J. Biol. Chem., May 26, 2000; 275(22): 16543 - 16549. [Abstract] [Full Text] [PDF]

				M. Norlin, U. Andersson, I. Bjorkhem, and K. Wikvall Oxysterol 7alpha -Hydroxylase Activity by Cholesterol 7alpha -Hydroxylase (CYP7A) J. Biol. Chem., October 27, 2000; 275(44): 34046 - 34053. [Abstract] [Full Text] [PDF]

				J. J. Repa, E. G. Lund, J. D. Horton, E. Leitersdorf, D. W. Russell, J. M. Dietschy, and S. D. Turley Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia. REVERSAL BY CHOLIC ACID FEEDING J. Biol. Chem., December 8, 2000; 275(50): 39685 - 39692. [Abstract] [Full Text] [PDF]